|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$54,927.00 |
2.86% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$51,822.51 |
2.70% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$51,558.21 |
2.69% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$48,908.08 |
2.55% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$48,731.88 |
2.54% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$48,459.41 |
2.53% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$46,739.96 |
2.44% |
| Waters Corporation |
WAT |
941848103 |
123 |
$46,129.92 |
2.40% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$45,682.30 |
2.38% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$45,427.86 |
2.37% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$42,215.09 |
2.20% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$42,084.32 |
2.19% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$41,399.01 |
2.16% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$41,352.90 |
2.15% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$41,005.22 |
2.14% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$40,876.60 |
2.13% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$40,669.42 |
2.12% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$40,417.08 |
2.11% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$39,939.84 |
2.08% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$39,583.92 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$39,607.44 |
2.06% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$39,327.77 |
2.05% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$39,429.36 |
2.05% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$38,589.15 |
2.01% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$38,639.53 |
2.01% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$38,325.30 |
2.00% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$38,285.82 |
1.99% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,574.25 |
1.96% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,518.65 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
177 |
$37,270.89 |
1.94% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$36,521.44 |
1.90% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$36,329.98 |
1.89% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$35,570.08 |
1.85% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$35,281.73 |
1.84% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$34,700.19 |
1.81% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$34,598.16 |
1.80% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,437.38 |
1.79% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$34,369.35 |
1.79% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$34,057.43 |
1.77% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$33,905.92 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$33,519.36 |
1.75% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$33,293.66 |
1.73% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$32,914.28 |
1.72% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$32,174.53 |
1.68% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$30,962.21 |
1.61% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$30,450.00 |
1.59% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$29,200.64 |
1.52% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$27,187.16 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$27,226.77 |
1.42% |
| US Dollar |
$USD |
|
9,588 |
$9,587.59 |
0.50% |
| New Zealand Dollar |
$NZD |
|
679 |
$385.78 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Japanese Yen |
$JPY |
|
-1 |
$0.00 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|